AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
  3. Financials
  4. Cash and cash equivalents

TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.【JP:E25678】

Market cap
P/E ratio
SummaryFinancialsDividendsHistoryWorkforce
Period EndCash and cash equivalents (Million JPY)YoY (%)
Mar 31, 2023255,966-3.43%
Mar 31, 2022265,049+5.94%
Mar 31, 2021250,178+11.78%
Mar 31, 2020223,814-20.79%
Mar 31, 2019282,567+28.46%
Mar 31, 2018219,973+9.29%
Mar 31, 2017201,275+16.92%
Mar 31, 2016172,142+7.87%
Mar 31, 2015159,587+9.82%
Mar 31, 2014145,320+23.88%
Mar 31, 2013117,303

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)